Factors Involved in Delaying Initiation of Adjuvant Chemotherapy After Breast Cancer Surgery [0.03%]
影响乳腺癌术后辅助化疗启动时间的因素分析
C Meyer,C Bailleux,E Chamorey et al.
C Meyer et al.
Background: Delays in initiating adjuvant chemotherapy after breast cancer surgery seems to have an impact on patients' risk of relapse and their survival rate. The aim of this retrospective study was to identify factors ...
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study [0.03%]
抗HER2治疗联合阿特朱单抗对早期或转移性乳腺癌肿瘤免疫微环境的影响：Ⅰb期临床研究结果
Erika P Hamilton,Virginia Kaklamani,Carla Falkson et al.
Erika P Hamilton et al.
Background: Despite advances, there continues to be unmet need in breast cancer. Combining anti-programmed death-ligand 1 (PD-L1) cancer immunotherapy atezolizumab with other targeted therapies may enhance T-cell-dependen...
Clinical Trial
Clinical breast cancer. 2021 Dec;21(6):539-551. DOI:10.1016/j.clbc.2021.04.011 2021
Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial [0.03%]
aromatherapy plus music therapy改善乳腺癌患者术前和术后疼痛强度和焦虑评分：一项随机对照试验
Chao Deng,Yijia Xie,Yan Liu et al.
Chao Deng et al.
Introduction: To investigate the effect of perioperative aromatherapy (AT) or/plus music therapy (MT) on pain and anxiety level, and the potential mechanism in women experiencing breast cancer surgery. ...
Randomized Controlled Trial
Clinical breast cancer. 2022 Feb;22(2):115-120. DOI:10.1016/j.clbc.2021.05.006 2022
Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study [0.03%]
现代乳腺癌免疫组化和原位杂交检测HER2过表达/基因扩增不一致的单中心经验及文献汇总分析研究
Raima Memon,Carlos N Prieto Granada,Shuko Harada et al.
Raima Memon et al.
Background: Human epidermal growth factor 2 (HER2) amplification and/or overexpression occurs in 12% to 25% of breast cancers. Accurate detection of HER2 is critical in predicting response to HER2-targeted therapy. Both i...
Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome? [0.03%]
社区多医院协作卫生体系中乳腺癌手术延误的相关因素：手术延误影响预后的时机分析
Judy A Tjoe,Kayla Heslin,Ana C Perez Moreno et al.
Judy A Tjoe et al.
Background: Multiple factors influence the time elapsed between diagnosis of breast cancer and surgical extirpation of the primary tumor. The disease-free interval between resection of primary breast cancer and first evid...
An Evaluation of Clinicopathological Correlation and Outcome of Human Epidermal Growth Factor Receptor 2 Subgroups Reclassified According to the Latest ASCO/CAP Guideline [0.03%]
根据美国病理学家协会最新指南重新分类的人表皮生长因子受体2亚组的临床病理相关性及结局的评估
Chao Wang,Julia Y Tsang,Ivan K Poon et al.
Chao Wang et al.
Background: The latest American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline has updated the interpretation of uncommon human epidermal growth factor receptor 2 (HER2) in situ hybri...
Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer [0.03%]
识别乳腺癌差异表达的血浆长链非编码RNA作为潜在生物标志物
Minghui Wang,Huilin Liu,Wenyao Wu et al.
Minghui Wang et al.
Background: Breast cancer is the most common malignant tumor in women and is not easy to diagnose. Increasing evidence has underscored that long non-coding RNAs (lncRNAs) play important regulatory roles in the occurrence ...
Value of Ultrasound-Guided Biopsy in Evaluating Internal Mammary Lymph Node Metastases in Breast Cancer [0.03%]
乳腺癌锁骨上淋巴结转移的超声内乳淋巴结活检价值评估分析
Xiaohui Ji,Diancheng Li,Dongxia Gao et al.
Xiaohui Ji et al.
Objectives: This retrospective study aimed to assess the value of a real-time, ultrasound-guided biopsy in evaluating internal mammary lymph nodes (IMLNs) in breast cancer. ...
Rates of Ipsilateral Local-regional Recurrence in High-risk Patients Undergoing Immediate Post-mastectomy Reconstruction (AFT-01) [0.03%]
术后即刻重建患者同侧局部复发率（AFT-01）
Christina M Dudley,Alyssa A Wiener,Trista J Stankowski-Drengler et al.
Christina M Dudley et al.
Background: Some surgeons remain hesitant to perform immediate breast reconstruction (IBR) in patients with higher risk cancers owing to concerns about cancer recurrence and/or detection. Our objective was to determine th...
Jajini Varghese,Shireen Gohari,Fatima Regrag et al.
Jajini Varghese et al.
Increased breast density is a risk factor for breast cancer and can mask cancer on mammography. This survey attempts to understand clinician views regarding breast density notification in the United Kingdom. Two separate breast density surv...